Overview
What is Spondyloarthritis Research And Treatment Network?
Spondyloarthritis Research and Treatment Network (SPARTAN) is a nonprofit organization based in Portland, Oregon. Their primary mission is to foster research and education in Spondyloarthritis (SpA), a group of inflammatory joint diseases. They achieve this goal by engaging in various research projects, supporting young researchers, and conducting an annual meeting to highlight significant education and research programs in the field of SpA. The annual meeting serves as a platform for expert researchers to collaborate and identify unmet needs in SpA research and therapy. SPARTAN's vision is a world free of SpA, achieved through leadership in research and education. The organization's annual meeting in 2022 was a hybrid event, attracting 130 attendees in person and 50 virtually. The scientific sessions feature prominent international experts in their respective fields. Additionally, SPARTAN holds a pre-meeting workshop for rheumatology fellows and other trainees.
Official website here: www.spartangroup.org
Is Spondyloarthritis Research And Treatment Network legitimate?
Spondyloarthritis Research And Treatment Network is a legitimate nonprofit organization registered as a 501(c)(3) entity. Spondyloarthritis Research And Treatment Network submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $0
For more financial information, click here
Official website here: www.spartangroup.org
What is the mission statement of Spondyloarthritis Research And Treatment Network?
The Spondyloarthritis Research and Treatment Network's mission is centered around fostering research and education in the field of spondyloarthritis. They achieve this by engaging in various research projects, supporting young researchers, and hosting an annual meeting that highlights significant education and research programs. Their vision is a world free of spondyloarthritis, accomplished through leadership in research and education. The organization conducts an annual meeting, which serves to showcase advancements in spondyloarthritis research and treatment. This event encourages post-doctoral fellows to contribute to the mission of fostering research and education in the field of spondyloarthritis. The meeting is also a platform for experts and dedicated researchers to identify and address unmet needs in the field of spondyloarthritis research and therapy. The Spondyloarthritis Research and Treatment Network's annual meeting is attended by members from across North America, with a significant number participating virtually. In 2022, the meeting was held as a hybrid event, with attendance both in-person in Madison, Wisconsin, and virtually. The scientific sessions feature prominent international experts in their respective fields. Additionally, the meeting includes a trainee symposium, a pre-meeting workshop for rheumatology fellows and other trainees.
Official website here: www.spartangroup.org
Who is the CEO of Spondyloarthritis Research And Treatment Network?
Joerg Ermann Md is the Chair of Spondyloarthritis Research And Treatment Network.
Official website here: www.spartangroup.org
What is the revenue of Spondyloarthritis Research And Treatment Network?
Spondyloarthritis Research And Treatment Network's revenue in 2022 was $1,197,948.
Official website here: www.spartangroup.org
Who are the executives of Spondyloarthritis Research And Treatment Network and what are their salaries?
- Matthew Stoll Phd Md (Treasurer) [Trustee/Director]
- Joerg Ermann Md (Chair) [Trustee/Director]
- Judith Smith Phd Md (Past Chair) [Trustee/Director]
- Kristine Kuhn Phd Md (Vice Chair) [Trustee/Director]
- Siba Raychaudhuri Md (Director)
- Maureen Dubreuil Md (Director)
- Nigil Haroon Phd Md (Director)
- Walter Maksymowych Md (Secretary) [Trustee/Director]
- Marina Magrey Md (Director)
- John Reveille Md (Director)
- Runsheng Wang Md (Director)
Official website here: www.spartangroup.org
Where can I find the form 990 for Spondyloarthritis Research And Treatment Network?
The Spondyloarthritis Research And Treatment Network’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.spartangroup.org
Learn more at the official website: www.spartangroup.org
Mission Statement of Spondyloarthritis Research And Treatment Network
Spondyloarthritis Research and Treatment Network (SPARTAN) is an organization committed to fostering research and education in the field of spondyloarthritis across North America. Their mission is to lead the way in this area, engaging in various research projects and supporting young researchers. One of their key initiatives is an annual meeting that showcases significant education and research programs in spondyloarthritis. This gathering brings together dedicated researchers from across North America to identify and address unmet needs in the field of spondyloarthritis research and therapy. The annual meeting, which was a hybrid event in 2022 due to the pandemic, attracts members from throughout North America, with a total attendance of 130 in Madison, Wisconsin, and 50 online. Prominent international experts in their respective fields present in the scientific sessions, and the event also includes a trainee symposium, a pre-meeting workshop for rheumatology fellows and other trainees. SPARTAN's vision is a world free of spondyloarthritis, achieved through their leadership in research and education.
Impact
This information is meant to be a general summary of Spondyloarthritis Research And Treatment Network. Please take the time to review official sources before making any decisions based upon the content provided here.
Saturday, July 20, 2024
The Spondyloarthritis Research And Treatment Network has made a significant impact in fostering research and education in the field of spondyloarthritis in North America. Through research projects, support for young researchers, and annual meetings highlighting important advancements in spondyloarthritis research and treatment, SPARTAN has played a crucial role in advancing knowledge and understanding of this disease. By bringing together experts and dedicated researchers, SPARTAN has identified and addressed unmet needs in the field, contributing to a world free of spondyloarthritis through leadership in research and education.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
ANNUAL MEETING REGISTR
Revenue
$1,400
Organization Details
Founding Year
2013
Phone
(360) 600-2170
Principal Officer
Joerg Ermann Md
Main Address
PO BOX 55491, PORTLAND, OR, 97238
Website
www.spartangroup.org
NTEE Category
Code: G51 - Disease
If you are a representative of Spondyloarthritis Research And Treatment Network and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.